COVAX Performance — Columbia Small Cap Value and Inflection Fund, Class A
Data updated: 2026-07-29
COVAX returned +15.74% year to date and +35.85% over one year to May 2026. Annualised returns are +17.67% over 3 years and +7.40% over 5 years. The fund beat its US Small Value category average: $100 invested three years ago grew to $163, against $156 for the category, and to $136 over one year, against $129. Volatility over the past three years was 18.16% a year. In the 12 months to May 2026 the fund lost a net $82.7M, and assets reached $868.45M.
COVAX Growth of $100
What $100 invested in Columbia Small Cap Value and Inflection Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Small Value category average over the same months.
| Period | COVAX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $136 | $129 |
| 3 years (Jun 2023 – May 2026) | $163 | $156 |
| 5 years (Jun 2021 – May 2026) | $143 | $140 |
| Since data start (Sep 2019 – May 2026) | $221 | $210 |
COVAX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +15.74% |
| 1 year | +35.85% |
| 3 years (annualised) | +17.67% |
| 5 years (annualised) | +7.40% |
COVAX Annual Returns
Calendar-year total returns of Columbia Small Cap Value and Inflection Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +15.74% |
| 2025 | +7.93% |
| 2024 | +11.31% |
| 2023 | +13.76% |
| 2022 | −13.84% |
| 2021 | +33.71% |
| 2020 | +9.86% |
| 2019 (Sep–Dec) | +10.41% |
COVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +6.0% | +2.8% | −3.4% | +8.6% | +1.3% | — | — | — | — | — | — | — |
| 2025 | +2.0% | −4.4% | −6.6% | −3.9% | +5.0% | +4.9% | +1.2% | +8.2% | +0.6% | −1.3% | +2.6% | +0.2% |
| 2024 | −4.2% | +4.3% | +4.8% | −4.6% | +4.7% | −2.4% | +9.4% | −1.2% | +0.6% | −0.2% | +9.6% | −8.3% |
| 2023 | +7.8% | −1.1% | −5.3% | −0.5% | −3.4% | +8.2% | +5.9% | −4.1% | −5.4% | −5.3% | +8.0% | +10.2% |
| 2022 | −5.8% | +2.6% | +0.5% | −7.9% | +2.3% | −10.0% | +8.5% | −3.1% | −9.6% | +11.4% | +5.4% | −6.5% |
| 2021 | +5.2% | +9.8% | +4.1% | +3.5% | +2.5% | −0.6% | −3.4% | +2.4% | −0.4% | +6.8% | −2.6% | +2.9% |
| 2020 | −4.3% | −10.1% | −25.2% | +15.8% | +5.3% | +0.5% | +3.2% | +5.0% | −4.1% | +3.5% | +20.0% | +7.9% |
| 2019 | — | — | — | — | — | — | — | — | +3.0% | +1.6% | +2.3% | +3.1% |
COVAX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 18.16%
- 3-year Sharpe ratio: 0.73 (vs 4.5% risk-free rate)
- Best month: +10.20% (Dec 2023)
- Worst month: −8.30% (Dec 2024)
COVAX Fund Flows
Monthly money in and out of Columbia Small Cap Value and Inflection Fund, from SEC Form N-PORT.
- 12-month net flow: −$82.7M
- 12-month gross sales (incl. reinvestments): $256.7M
- Sales ÷ redemptions: 0.76×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $21.3M | $22.2M | −$927K |
| Apr 2026 | $14.2M | $16.1M | −$1.9M |
| Mar 2026 | $11.9M | $18.4M | −$6.5M |
| Feb 2026 | $9.8M | $18.5M | −$8.7M |
| Jan 2026 | $25.2M | $52.6M | −$27.4M |
| Dec 2025 | $88.6M | $39.1M | $49.5M |
| Nov 2025 | $8.3M | $30.7M | −$22.4M |
| Oct 2025 | $9.3M | $24.0M | −$14.7M |
| Sep 2025 | $7.8M | $49.5M | −$41.7M |
| Aug 2025 | $8.3M | $25.4M | −$17.0M |
| Jul 2025 | $8.8M | $25.2M | −$16.5M |
| Jun 2025 | $43.2M | $17.5M | $25.7M |
COVAX Assets Under Management
Net assets of Columbia Small Cap Value and Inflection Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $868.45M |
| 2026-02-28 | $826.37M |
| 2025-11-30 | $824.39M |
| 2025-08-31 | $886.95M |
| 2025-05-31 | $810.44M |
| 2025-02-28 | $868.80M |
| 2024-11-30 | $1.05B |
| 2024-08-31 | $1.03B |
| 2024-05-31 | $1.18B |
| 2024-02-29 | $1.27B |
| 2023-11-30 | $1.20B |
| 2023-08-31 | $1.28B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.